Prime Medicine, Inc. PRME

Updated: 9 Aug 2026

NASDAQ | Biotech | Gene Editing / Biotechnology

No signal published yet

We already track Prime Medicine and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.

Follow Prime Medicine free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Free
No email, no account, no signup.
Exchange
NASDAQ
Type
Biotech
Sector
Gene Editing / Biotechnology
We're already tracking Prime Medicine, Inc. — here are the latest events we've registered

Recent News

  • On August 6, 2026, Prime Medicine reported its second-quarter 2026 financial results and announced IND and CTA clearances in the U.S. and New Zealand to advance PM577a for Wilson Disease into Phase 1/2 clinical trials. The company also secured sole rights to PM647 for alpha-1 antitrypsin deficiency following a favorable arbitration ruling with Beam Therapeutics. As of June 30, 2026, Prime Medicine held $108.8 million in total cash, equivalents, and investments, expected to fund operations into 2027.

What Firelda Watch includes for Prime Medicine, Inc.

Add the company to your watchlist and get all of this automatically.

  • Free: 3 companies on your watchlist
  • Change history and monitoring for every company you follow
  • Sunday weekly brief — a short weekly roundup
  • Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of Prime Medicine, Inc. will be delivered in the same format.

Sample analyses in the same sector

Sample full analysis — same format your watchlist gets

Hansa Biopharma AB (publ)
HNSA
HOLD
Bioarctic
BIOA B
BUY
Sprint Bioscience AB (publ)
SPRINT
NEUTRAL
Xbrane Biopharma AB (publ)
XBRANE
HOLD
SynAct Pharma AB
SYNACT
HOLD

Biotech

More companies in this sector

Want to follow Prime Medicine, Inc.? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.

Follow Prime Medicine free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Prime Medicine, Inc. PRME
Prime Medicine — follow and we'll monitor it
Follow Prime Medicine free Follow free
Firelda provides general information and analysis, not personal investment advice. Content does not consider your financial situation or goals. Investments can rise and fall in value. Always do your own research.